Trofosfamide as a maintenance therapy for advanced soft tissue sarcoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033900

Enrollment

Registered

2024-03-18

Start date

2023-08-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue sarcoma

Interventions

Group 1: Patients with advanced soft tissue sarcoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Treatment with trofosfamide as maintenance therapy in the sarcoma center of the LMU between 01/2016-12/2023

Exclusion criteria

Exclusion criteria: Treatment with trofosfamide as first-line therapy or not as maintenance therapy

Design outcomes

Primary

Measure	Time frame
progression-free survival	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Germany

Contacts

Public ContactLars Lindner

Medizinische Klinik und Poliklinik III, AG Hyperthermie

Lars.Lindner@med.uni-muenchen.de+49 89 4400-74768

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026